Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the safety and preliminary efficacy of γδ T cell therapy for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• T-cell therapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED